Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–362 of 362

A pathogenic role for γ δ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse
Rajan, A. J., Gao, Y., Raine, C. S., & Brosnan, C. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.941 · Cited by 124
Elevated serum levels of IFN-γ, IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage
Hohnoki, K., Inoue, A., & Koh, C. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00053-8 · Cited by 121
Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis
Olsson, T. P., Sun, J., Hillert, J. A., Höjeberg, B., Ekre, H.-P. T., Andersson, G., Olerup, O., & Link, H. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220431 · Cited by 120
Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor
Chen, M., Valenzuela, R. M., & Dhib-Jalbut, S. S. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00177-1 · Cited by 118
Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements.
Stinissen, P., Vandevyver, C. D. B., Medaer, R., Vandegaer, L., van Nies, J., Tuyls, L., Hafler, D. A., Raus, J., & Zhang, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4883 · Cited by 116
Effective and selective immune surveillance of the brain by MHC class I‐restricted cytotoxic T lymphocytes
Cabarrocas, J., Bauer, J., Piaggio, E., Liblau, R., & Lassmann, H. (2003) · European Journal of Immunology · doi:10.1002/eji.200323492 · Cited by 115
A meta-analysis of whole genome linkage screens in multiple sclerosis
(2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.08.009 · Cited by 115
The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis
Sindic, C. J. M., Monteyne, P., & Laterre, E.-C. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90233-x · Cited by 113
Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-β) treatment
Özenci, V., Kouwenhoven, M. C. M., Huang, Y.-M., Kivisäkk, P., & Link, H. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01175.x · Cited by 111
Interferon-γ Modulates Human Oligodendrocyte Susceptibility To Fas-Mediated Apoptosis
Pouly, S., Becher, B., Blain, M., & Antel, J. P. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.4.280 · Cited by 110
Molecular mechanisms of axonal damage in inflammatory central nervous system diseases
Neumann, H. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000073926.19076.29 · Cited by 107
On the immunopathology of plaque development and repair in multiple sclerosis
Raine, C. S., & Scheinberg, L. C. (1988) · Journal of Neuroimmunology · doi:10.1016/0165-5728(88)90160-9 · Cited by 106
Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges.
Trebst, C., & Ransohoff, R. M. (2001) · PubMed · doi:10.1001/archneur.58.12.1975 · Cited by 106
Macrophage inflammatory protein-1α(MIP-1α), MIP-1β, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions
Boven, L. A., Montagne, L., Nottet, H. S. L. M., & Groot, C. J. A. D. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01334.x · Cited by 105
Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosis
Warren, K. G., Catz, I., Johnson, E. S., & Mielke, B. W. (1994) · Annals of Neurology · doi:10.1002/ana.410350307 · Cited by 104
Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
Muraro, P. A., Vergelli, M., Kalbus, M., Banks, D. E., Nagle, J. W., Tranquill, L. R., Nepom, G. T., Biddison, W. E., McFarland, H. F., & Martinꝉ, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119539 · Cited by 101
Self-citation
Normal rat serum cytotoxicity against syngeneic oligodendrocytes
Scolding, N. J., Morgan, B. P., Houston, A., Campbell, A. K., Linington, C., & Compston, D. A. S. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90030-0 · Cited by 100
Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege
Head, J. R., & Griffin, W. S. T. (1985) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1985.0039 · Cited by 100
Exacerbation of Viral and Autoimmune Animal Models for Multiple Sclerosis by Bacterial DNA
Tsunoda, I., Tolley, N. D., Theil, D. J., Whitton, J. L., Kobayashi, H., & Fujinami, R. S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00537.x · Cited by 100
Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease
Bieganowska, K. D., Ausubel, L. J., Modabber, Y., Slovik, E., Messersmith, W. A., & Hafler, D. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1585 · Cited by 100
Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis
Vergelli, M., Hemmer, B., Muraro, P. A., Tranquill, L. R., Biddison, W. E., Sarin, A., McFarland, H. F., & Martinꝉ, R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2756 · Cited by 98
Self-citation
Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions
O’Connor, K. C., Chitnis, T., Griffin, D. E., Piyasirisilp, S., Bar‐Or, A., Khoury, S. J., Wucherpfennig, K. W., & Hafler, D. A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00002-x · Cited by 98
The development of Cop 1 (Copaxone®), and innovative drug for the treatment of multiple sclerosis: personal reflections
Arnon, R. (1996) · Immunology Letters · doi:10.1016/0165-2478(96)02506-0 · Cited by 95
IL-18 is linked to raised IFN-γ in multiple sclerosis and is induced by activated CD4+ T cells via CD40–CD40 ligand interactions
Karni, A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00018-8 · Cited by 95
Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis
Holz, A., Bielekova, B., Martinꝉ, R., & Oldstone, M. B. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1103 · Cited by 94
Self-citation
A role for natural killer cells in the immunopathogenesis of multiple sclerosis
Kastrukoff, L. F., Morgan, N., Zecchini, D., White, R., Petkau, A. J., Satoh, J., & Paty, D. W. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00014-9 · Cited by 94
Perforin Protects Against Autoimmunity in Lupus-Prone Mice
Peng, S. L., Moslehi, J. J., Robert, M., & Craft, J. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.652 · Cited by 94
Symptomatic Epstein-Barr virus infection and multiple sclerosis.
Martyn, C. N., Cruddas, M., & Compston, D. A. S. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.2.167 · Cited by 94
Combinatorial Peptide Libraries and Biometric Score Matrices Permit the Quantitative Analysis of Specific and Degenerate Interactions Between Clonotypic TCR and MHC Peptide Ligands
Zhao, Y., Gran, B., Pinilla, C., Markovic‐Plese, S., Hemmer, B., Tzou, A., Whitney, L. W., Biddison, W. E., Martinꝉ, R., & Simon, R. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2130 · Cited by 93
Self-citation
T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB1*0401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells
Forsthuber, T. G., Shive, C. L., Wienhold, W., de Graaf, K., Spack, E. G., Sublett, R. D., Melms, A., Kort, J., Racke, M. K., & Weissert, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7119 · Cited by 92
Augmented expression of tumour necrosis factor-α and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis
Navikas, V., He, B., Link, J., Haglund, M., Söderström, M. B., Fredrikson, S., Ljungdahl, Å., Höjeberg, B., Qiao, J., Olsson, T. P., et al. (1996) · Brain · doi:10.1093/brain/119.1.213 · Cited by 90
HL-A Antigen Frequencies in Multiple Sclerosis
Bertrams, J., & Kuwert, E. K. (2008) · European Neurology · doi:10.1159/000114414 · Cited by 90
Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.
Mycko, M., Papoian, R., Boschert, U., Raine, C., & Selmaj, K. (2004) · Clinical neurology and neurosurgery (Dutch-Flemish ed. Print) · doi:10.1016/j.clineuro.2004.02.019 · Cited by 88
Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules
Chou, Y. K., Vainiene, M., Whitham, R. H., BOURDETTE, D. N., Chou, C. H. ‐., Hashim, G. A., Offner, H., & Vandenbark, A. A. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490230211 · Cited by 88
Antibody Association with a Novel Model for Primary Progressive Multiple Sclerosis: Induction of Relapsing‐Remitting and Progressive Forms of EAE in H2S Mouse Strains
Tsunoda, I., Kuang, L., Theil, D. J., & Fujinami, R. S. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00272.x · Cited by 86
Clinical relapses of multiple sclerosis are associated with ‘novel’ valleys in natural killer cell functional activity
Kastrukoff, L. F., Lau, A. S., Wee, R., Zecchini, D., White, R., & Paty, D. W. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.001 · Cited by 86
A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions
van Kooyk, Y., & Geijtenbeek, T. B. H. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18605.x · Cited by 84
Human herpes virus 6 and multiple sclerosis
Moore, F. G. A., & Wolfson, C. M. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.01251.x · Cited by 83
Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation
Johns, T. G., & Bernard, C. C. A. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00005-9 · Cited by 83
Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis
Greer, J. M. (1997) · Brain · doi:10.1093/brain/120.8.1447 · Cited by 83
Inhibition of Autoimmune T Cell Responses in the DA Rat by Bone Marrow-Derived NK Cells In Vitro: Implications for Autoimmunity
Smeltz, R. B., Wolf, N. A., & Swanborg, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1390 · Cited by 82
Intrathecal activation of the complement system and disability in multiple sclerosis
Sellebjerg, F. T., Jaliashvili, I., Christiansen, M., & Garred, P. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00086-0 · Cited by 79
Intravenous immunoglobulin treatment in multiple sclerosis.
Achiron, A., Cohen, I. R., Lider, O., & Melamed, E. (1995) · PubMed · Cited by 79
Mast cells: new targets for multiple sclerosis therapy?
Zappulla, J. P., Arock, M., Mars, L. T., & Liblau, R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00250-3 · Cited by 78
Multiple susceptibility loci for multiple sclerosis
The Multiple Sclerosis Genetics Group (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.19.2251 · Cited by 77
Identification of a novel T cell epitope of human proteolipid protein (residues 40–60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients
Pelfrey, C. M., Trotter, J. L., Tranquill, L. R., & McFarland, H. F. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90231-m · Cited by 76
Viruses and T Cell Turnover: Evidence for Bystander Proliferation
Tough, D. F., & Sprent, J. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00699.x · Cited by 76
Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders
Muraro, P. A., Wandinger, K., Bielekova, B., Gran, B., Marques, A. R., Utz, U., McFarland, H. F., Jacobson, S., & Martinꝉ, R. (2002) · Brain · doi:10.1093/brain/awg021 · Cited by 74
Self-citation
A Systematic Review of Several Potential Non-Genetic Risk Factors for Multiple Sclerosis
Coo, H., & Aronson, K. J. (2004) · Neuroepidemiology · doi:10.1159/000073969 · Cited by 74
TGF-β induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia
Schlapbach, R., Spanaus, K., Malipiero, U., Lens, S. M. A., Tasinato, A., Tschopp, J., & Fontana, A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12 · Cited by 74
Isolation and characterization of autoreactive moteolioid protein‐peptide specific T‐cell clones from multiple sclerosis patients
Correale, J. D., McMillan, M., McCarthy, K. A., Le, T. D., & Weiner, L. P. (1995) · Neurology · doi:10.1212/wnl.45.7.1370 · Cited by 74
Opsonization with Antimyelin Antibody Increases the Uptake and Intracellular Metabolism of Myelin in Inflammatory Macrophages
Trotter, J., deJong, L. J., & Smith, M. E. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00679.x · Cited by 73
INTRATHECAL IMMUNOGLOBULIN M SYNTHESIS IN MULTIPLE SCLEROSIS RELATIONSHIP WITH CLINICAL AND CEREBROSPINAL FLUID PARAMETERS
Sharief, M. K., & Thompson, E. J. (1991) · Brain · doi:10.1093/oxfordjournals.brain.a101856 · Cited by 73
The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS)
Kaye, J. F., de Rosbo, N. K., Mendel, I., Flechter, S., Hoffman, M. A., Yust, I., & Ben‐Nun, A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00168-x · Cited by 72
Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis.
Colombo, E., Bánki, K., Tatum, A. H., Daucher, J. W., Ferrante, P., Murray, R. S., Phillips, P. E., & Perl, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119281 · Cited by 72
Analysis of the Role of Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response
Ridgway, W. M., Ito, H., Fassò, M., Chen, Y., & Fathman, C. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2267 · Cited by 72
Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries.
Cortese, I., Tafi, R., Grimaldi, L. M. E., Martino, G., Nicosia, A., & Cortese, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11063 · Cited by 71
Familial Alzheimer's disease: Site of mutation influences clinical phenotype
Lippa, C. F., Swearer, J. M., Kane, K., Nochlin, D., Bird, T. D., Ghetti, B. F., Nee, L. E., George‐Hyslop, P. S., Pollen, D. A., & Drachman, D. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3 · Cited by 67
Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls
Munschauer, F. E., Hartrich, L., Stewart, C. C., & Jacobs, L. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00115-9 · Cited by 66
Increased mRNA Expression of IL‐10 in Mononuclear Cells in Multiple Sclerosis and Optic Neuritis
Navikas, V., Link, J., Palasik, W., Söderström, M. B., Fredrikson, S., Olsson, T. P., & Link, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03550.x · Cited by 65
Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis
Chitnis, T., & Khoury, S. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.025 · Cited by 65
Contribution of Individual Amino Acids Within MHC Molecule or Antigenic Peptide to TCR Ligand Potency
Hemmer, B., Pinilla, C., Gran, B., Vergelli, M., Ling, N., Conlon, P. J., McFarland, H. F., Houghten, R. A., & Martinꝉ, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.861 · Cited by 64
Self-citation
A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule
Vergelli, M., Le, H., van Noort, J. M., Dhib-Jalbut, S. S., McFarland, H. F., & Martinꝉ, R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.679 · Cited by 63
Self-citation
Monocytes Are Differentially Activated Through HLA-DR, -DQ, and -DP Molecules Via Mitogen-Activated Protein Kinases
Matsuoka, T., Tabata, H., & Matsushita, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2202 · Cited by 61
Blood T-cell receptor chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution
Laplaud, D. A. (2004) · Brain · doi:10.1093/brain/awh119 · Cited by 61
HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.
Jaraquemada, D., Martinꝉ, R., Rosen‐Bronson, S., Flerlage, M., McFarland, H. F., & Long, E. O. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.9.2880 · Cited by 60
Self-citation
A humoral response to oligodendrocyte-specific protein in MS
Bronstein, J. M., Lallone, R. L., Seitz, R. S., Ellison, G. W., & Myers, L. W. (1999) · Neurology · doi:10.1212/wnl.53.1.154 · Cited by 60
T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells
Vergelli, M., Kalbus, M., Rojo, S. C., Hemmer, B., Kalbacher, H., Tranquill, L. R., Beck, H., McFarland, H. F., de Mars, R., Long, E. O., et al. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00075-1 · Cited by 59
Self-citation
Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis
Schmidt, S. (1997) · Brain · doi:10.1093/brain/120.8.1437 · Cited by 59
CD8+ Myelin Peptide-Specific T Cells Can Chemoattract CD4+ Myelin Peptide-Specific T Cells: Importance of IFN-Inducible Protein 10
Biddison, W. E., Cruikshank, W. W., Pelfrey, C. M., Taub, D. D., & Turner, R. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.444 · Cited by 58
Non-MHC-Restricted Cell-Mediated Lysis of Human Oligodendrocytes In Vitro: Relation with CD56 Expression
Antel, J. P., McCrea, E., Ladiwala, U., Qin, Y., & Becher, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1606 · Cited by 58
Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis
Weber, F., Polak, T. T., Günther, A., Kubuschok, B., Janovskaja, J., Bitsch, A., Poser, S., & Rieckmann, P. (1998) · Annals of Neurology · doi:10.1002/ana.410440109 · Cited by 58
Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis
Pender, M. P., Csurhes, P. A., Wolfe, N., Hooper, K. D., Good, M. F., McCombe, P., & Greer, J. M. (2003) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(02)00270-9 · Cited by 58
DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain
Fern�ndez, O., Fern�ndez, V., Alonso, A., Caballero, A., Luque, G., Bravo, M. J., Le�n, A., Mayorga, C., Leyva, L., & de Ram�n, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0350-2 · Cited by 57
Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice
Morris-Downes, M. M., McCormack, K., Baker, D., Sivaprasad, D., Natkunarajah, J., & Amor, S. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00460-x · Cited by 55
Decreases in Interleukin-4 Secretion by Invariant CD4−CD8−Vα24JαQ T Cells in Peripheral Blood of Patients with Relapsing–Remitting Multiple Sclerosis
Gausling, R., Trollmo, C., & Hafler, D. A. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4942 · Cited by 55
T cell vaccination in multiple sclerosis: results of a preliminary study
Zhang, J. Z., Rivera, V. M., Tejada-Simon, M. V., Yang, D., Hong, J., Li, S., Haykal, H. A., Killian, J., & Zang, Y. C. Q. (2002) · Journal of Neurology · doi:10.1007/pl00007867 · Cited by 54
Killing of rat glial cells by complement: Deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis
Piddlesden, S. J., & Morgan, B. P. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90189-6 · Cited by 54
Differential release of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis
Sindern, E., Niederkinkhaus, Y., Henschel, M., Ossege, L. M., Patzold, T., & Malin, J. P. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.104002088.x · Cited by 52
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study
Lily, O. (2004) · Brain · doi:10.1093/brain/awh031 · Cited by 52
Identification of an epitope derived from human proteolipid protein that can induce autoreactive CD8+ cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism
Honma, K., Parker, K. C., Becker, K. G., McFarland, H. F., Coligan, J. E., & Biddison, W. E. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00161-0 · Cited by 51
High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes
Weissert, R., Kühle, J., de Graaf, K. L., Wienhold, W., Herrmann, M. M., Müller, C. A., Forsthuber, T. G., Wiesmüller, K., & Melms, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.548 · Cited by 50
Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis
Das, P., Drescher, K. M., Geluk, A., Bradley, D. S., Rodriguez, M., & David, C. S. (2000) · Human Immunology · doi:10.1016/s0198-8859(99)00135-4 · Cited by 50
Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus–transformed B cells
Holmøy, T., & Vartdal, F. (2004) · Journal of NeuroVirology · doi:10.1080/13550280490261671 · Cited by 50
Retargeting T Cell-Mediated Inflammation: A New Perspective on Autoantibody Action
Lou, Y., Park, K.-K., Agersborg, S. S., Alard, P., & Tung, K. S. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5251 · Cited by 49
Src, ras, and rac mediate the migratory response elicited by NGF and PMA in PC12 cells
Altun-Gultekin, Z. F., & Wagner, J. A. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960515)44:4 · Cited by 49
Myelin basic protein‐specific T‐cell responses in identical twins discordant or concordant for multiple sclerosis
Martinꝉ, R., Voskuhl, R. R., Flerlage, M., McFarlin, D. E., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340405 · Cited by 49
Self-citation
Role of viruses in etiology and pathogenesis of multiple sclerosis
Soldan, S. S., & Jacobson, S. (2001) · Advances in virus research · doi:10.1016/s0065-3527(01)56037-6 · Cited by 48
Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1α
Angulo, I., Rullás, J., Campillo, J. A., Obregón, E., Heath, A. W., Howard, M., Muñoz‐Fernández, M. Á., & Subiza, J. L. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200005)30:5 · Cited by 48
Complementarity-Determining Region 3 Spectratyping Analysis of the TCR Repertoire in Multiple Sclerosis
Matsumoto, Y., Yoon, W. K., Jee, Y., Fujihara, K., Misu, T., Sato, S., Nakashima, I., & Itoyama, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4846 · Cited by 47
HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides
Trotter, J. L., Damico, C. A., Cross, A. H., Pelfrey, C. M., Karr, R. W., Fu, X.-T., & McFarland, H. F. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00007-6 · Cited by 47
Ueber das Vorkommen der sogenannten „Mastzellen” bei pathologischen Veränderungen des Gehirns
Neumann, J. H. L. (1890) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01884453 · Cited by 47
HLA-DR2–restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice
Kawamura, K., Yamamura, T., Yokoyama, K., Chui, D.-H., Fukui, Y., Sasazuki, T., Inoko, H., David, C. S., & Tabira, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8407 · Cited by 47
Cytokine analysis in multiple sclerosis by competitive RT - PCR: A decreased expression of IL-10 and an increased expression of TNF-α in chronic progression
Huang, W., Huang, P., Link, H., & Hillert, J. A. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500507 · Cited by 46
The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study
Koehler, N. K. U., Genain, C. P., Giesser, B. S., & Hauser, S. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5920 · Cited by 45
Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry
OLSON, J. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.11.010 · Cited by 44
Spinal fluid lymphocytes from a subgroup of multiple sclerosis patients respond to mycobacterial antigens
Birnbaum, G., Kotilinek, L., & Albrecht, L. (1993) · Annals of Neurology · doi:10.1002/ana.410340106 · Cited by 43
Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis
Andersson, M., Yu, M., Söderström, M. B., Weerth, S., Baig, S., Linington, C., Solders, G., & Link, H. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00391.x · Cited by 43
Activation of Complement by Myelin: Identification of C1‐Binding Proteins of Human Myelin from Central Nervous Tissue
Vanguri, P., & Shin, M. L. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb01773.x · Cited by 43
HLA-DP: A Class II Restriction Molecule Involved in Epitope Spreading During the Development of Multiple Sclerosis
Yu, M., Kinkel, R. P., Weinstock‐Guttman, B., Cook, D. J., & Tuohy, V. K. (1998) · Human Immunology · doi:10.1016/s0198-8859(97)00252-8 · Cited by 42
Mast cells and multiple sclerosis: a quantitative analysis
Krüger, P. G. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00331.x · Cited by 42
γδ T Cell Receptor Analysis Supports a Role for HSP 70 Selection of Lymphocytes in Multiple Sclerosis Lesions
Battistini, L., Salvetti, M., Ristori, G., Falcone, M., Raine, C. S., & Brosnan, C. F. (1995) · Molecular Medicine · doi:10.1007/bf03401592 · Cited by 41
Unique Clinical and Pathological Features in HLA-DRB1*0401–restricted MBP 111–129–specific Humanized TCR Transgenic Mice
Quandt, J. A., Baig, M. S., Yao, K., Kawamura, K., Huh, J., Ludwin, S. K., Bian, H.-J., Bryant, M., Quigley, L., Nagy, Z. A., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030994 · Cited by 41
Self-citation
T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients
Muraro, P. A., Kalbus, M., Afshar, G., McFarland, H. F., & Martinꝉ, R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00229-1 · Cited by 39
Self-citation
Viruses, Hidden Self‐Epitopes and Autoimmunity
Barnaba, V. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00910.x · Cited by 39
Class ii major histocompatibility complex gene sequences in rheumatoid arthritis. The third diversity regions of both DRβ1 genes in two DR1, DRw10–positive individuals specify the same inferred amino acid sequence as the DRβ1 and DRβ2 Genes of a DR4 (Dw14) haplotype
Merryman, P. F., Crapper, R. M., Lee, S., Gregersen, P. K., & WINCHESTER, R. J. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320304 · Cited by 38
Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS
Killestein, J., Eikelenboom, M. J., Izeboud, T., Kalkers, N. F., Adèr, H. J., Barkhof, F., van Lier, R. A. W., Uitdehaag, B. M. J., & Polman, C. H. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00265-0 · Cited by 38
T cell receptor γδ repertoire is skewed in cerebrospinal fluid of multiple sclerosis patients: molecular and functional analyses of antigen‐reactive γδ clones
Nick, S., Pileri, P., Tongiani, S., Uematsu, Y., Kappos, L., & Libero, G. D. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250208 · Cited by 37
Human cytotoxic T‐cell recognition of a synthetic peptide of myelin basic protein
Richert, J. R., Robinson, E., Deibler, G. E., Martenson, R. E., Dragovic, L. J., & Kies, M. W. (1989) · Annals of Neurology · doi:10.1002/ana.410260306 · Cited by 37
Identification of a second T cell epitore of human proteolipid protein (residues 89–106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients
Pelfrey, C. M., Trotter, J. L., Tranquill, L. R., & McFarland, H. F. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90025-6 · Cited by 36
Expansion of antigen-specific T cells from cerebrospinal fluid of patients with multiple sclerosis
Richert, J. R., McFarlin, D. E., ROSE, J. W., McFarland, H. F., & Greenstein, J. I. (1983) · Journal of Neuroimmunology · doi:10.1016/0165-5728(83)90052-8 · Cited by 35
A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis
Arbour, N. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00080-8 · Cited by 35
CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls
de Oliveira, E. M. L. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00106-3 · Cited by 35
Regulation of Experimental Autoimmune Encephalomyelitis by Chemokines and Chemokine Receptors
Elhofy, A., Kennedy, K. J., Fife, B. T., & Karpus, W. J. (2002) · Immunologic Research · doi:10.1385/ir:25:2:167 · Cited by 35
Opsonization of normal myelin by anti-myelin antibodies and normal serum
Goldenberg, P. Z., Kwon, E. E., Benjamins, J. A., Whitaker, J. N., Quarles, R. H., & Prineas, J. W. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90035-0 · Cited by 34
Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNγ-producing effector cells
Calabresi, P. A., Yun, S. H., Allie, R., & Whartenby, K. A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00106-6 · Cited by 33
Interleukin‐12 and Perforin mRNA Expression is Augmented in Blood Mononuclear Cells in Multiple Sclerosis
Matusevicius, Kivisäkk, Navikas, Söderström, Fredrikson, S., & Link (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00344.x · Cited by 33
2′,3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases
Rösener, M., Muraro, P. A., Riethmüller, A., Kalbus, M., Sappler, G., Thompson, R. J., Lichtenfels, R., Sommer, N., McFarland, H. F., & Martinꝉ, R. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00230-5 · Cited by 32
Self-citation
Antibody‐mediated suppression of Vβ5.2/5.3+ T cells in multiple sclerosis: Results from an MRI‐monitored phase II clinical trial
Killestein, J., Olsson, T. P., Wallström, E., Svenningsson, A., Khademi, M., Blumhardt, L. D., Fagius, J., Hillert, J. A., Landtblom, A., Edenius, C., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10146 · Cited by 31
Immune Tolerance to Myelin Proteins
Seamons, A., Perchellet, A., & Goverman, J. M. (2003) · Immunologic Research · doi:10.1385/ir:28:3:201 · Cited by 30
Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease
Waldner, H., Collins, M. K., & Kuchroo, V. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419388 · Cited by 30
Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein
Wang, L.-Y., & Fujinami, R. S. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00235-4 · Cited by 29
Reduced expression of peptide‐loaded HLA class I molecules on multiple sclerosis lymphocytes
Li, F., Linan, M. J., Stein, M. C., & Faustman, D. L. (1995) · Annals of Neurology · doi:10.1002/ana.410380205 · Cited by 28
Twin studies and multiple sclerosis
McFarland, H. F. (1992) · Annals of Neurology · doi:10.1002/ana.410320603 · Cited by 28
Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis
Warren, K. G., & Catz, I. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90078-d · Cited by 28
Differences between T‐cell reactivities to major myelin protein‐derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls
Minohara, M., Ochi, H., Matsushita, S., Irie, A., Nishimura, Y., & Kira, J. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057005447.x · Cited by 28
T‐cell responses to oligodendrocyte‐specific protein in multiple sclerosis
Vu, T., Myers, L. W., Ellison, G. W., Mendoza, F., & Bronstein, J. M. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1241 · Cited by 26
Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis
Nakashima, I., Fujihara, K., Misu, T., Okita, N., Takase, S., & Itoyama, Y. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00389-1 · Cited by 26
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis
Calabresi, P. A., Martinꝉ, R., & Jacobson, S. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909029751 · Cited by 25
Self-citation
Specific Proliferation Towards Myelin Antigens in Patients with Multiple Sclerosis During a Relapse
Sáez-Torres, I., Brieva, L., Espejo, C., Barrau, M. A., Montalbán, X., & Martínez-Cáceres, E. M. (2002) · Autoimmunity · doi:10.1080/08916930290005927 · Cited by 25
An immunochemical comparison of human myelin basic protein and its modified, citrullinated form, C8
Whitaler, J. N., Kirk, K. A., Herman, P. K., Zhou, S.-R., Goodin, R. R., Moscarello, M. A., & Wood, D. D. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90045-m · Cited by 25
HLA and MS
Hillert, J. A., & Olerup, O. (1993) · Neurology · doi:10.1212/wnl.43.11.2426-a · Cited by 25
HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis
Sellebjerg, F. T., Jensen, J. S., Madsen, H., & Svejgaard, A. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550404.x · Cited by 24
TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences
Kondo, T., Yamamura, T., Inobe, J.-I., Ohashi, T., Takahashi, K., & Tabira, T. (1996) · International Immunology · doi:10.1093/intimm/8.1.123 · Cited by 23
Ex vivo detection of myelin basic protein‐reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes
Hong, J., Zang, Y. C. Q., Li, S., Rivera, V. M., & Zhang, J. Z. (2004) · European Journal of Immunology · doi:10.1002/eji.200324790 · Cited by 21
γδ T-cell–human glial cell interactions. II. Relationship between heat shock protein expression and susceptibility to cytolysis
Freedman, M. S., Bitar, R., & Antel, J. P. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00218-4 · Cited by 20
CD4 T‐cell epitopes of human α B‐crystallin
Chou, Y. K., Burrows, G., Latocha, D. H., Wang, C.-H., Subramanian, S., Bourdette, D., & Vandenbark, A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20000 · Cited by 20
Human Cerebrospinal Fluid Immunology
Trotter, J. L., & Rust, R. S. (1989) · Springer eBooks · doi:10.1007/978-1-4613-1591-9_8 · Cited by 19
Fine analysis of cytolytic and natural killer T lymphocytes in the CSF in multiple sclerosis and other neurologic diseases
Weber, W. E. J., Buurman, W. A., Vandermeeren, M., Medaer, R., & Raus, J. C. M. (1987) · Neurology · doi:10.1212/wnl.37.3.419 · Cited by 19
The pathology of primary progressive multiple sclerosis
Lucchinetti, C., & Brück, W. (2004) · Multiple Sclerosis · doi:10.1191/1352458504ms1027oa · Cited by 19
Correlation between MR and clinical findings of disease activity in multiple sclerosis.
McFarland, H. F. (1999) · PubMed Central · Cited by 19
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis
Dharmasaroja, P. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00349-0 · Cited by 18
Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires
Haegert, D. G., Galutira, D., MURRAY, T. J., O'Connor, P. W., & Gadag, V. G. (2003) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02327.x · Cited by 17
Role of chemokines and their receptors in the pathogenesis of multiple sclerosis
Sindern, E. (2004) · Frontiers in bioscience · doi:10.2741/1238 · Cited by 17
Interleukin‐12 is detectable in sera of patients with multiple sclerosis — association with chronic progressive disease course?
Heesen, C., Sieverding, F., Schoser, B. G. H., Hadji, B., & Kunze, K. (1999) · European Journal of Neurology · doi:10.1046/j.1468-1331.1999.650591.x · Cited by 17
Flow Cytometric Analysis of In Vitro Proinflammatory Cytokine Secretion in Peripheral Blood from Multiple Sclerosis Patients
Nguyen, L. T., Ramanathan, M. K., Munschauer, F. E., Brownscheidle, C. M., Krantz, S., Umhauer, M., Miller, C., DeNardin, E., & Jacobs, L. D. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020555711228 · Cited by 16
T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid
Holmøy, T., Vandvik, B., & Vartdal, F. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms906oa · Cited by 16
HLA-DM polymorphisms do not associate with multiple sclerosis: an association study with analysis of myelin basic protein T cell specificity
Ristori, G., Carcassi, C., Lai, S., Fiori, P., Cacciani, A., Floris, L. A., Montesperelli, C., Giovanni, S. D., Buttinelli, C., Contu, L., et al. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00069-6 · Cited by 13
Demyelination in cultures of rat cerebellum produced by experimental allergic encephalomyelitic serum.
Bornstein, M. B., & Appel, S. H. (1959) · PubMed · Cited by 13
Peptide-MHC interaction in autoimmunity
Fairchild, P. J., & Wraith, D. C. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90056-k · Cited by 11
Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system
Gestri, D. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.6.767 · Cited by 10
Lack of over-expression of T cell receptor Vβ5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controls
Afshar, G., Muraro, P. A., McFarland, H. F., & Martinꝉ, R. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00215-4 · Cited by 9
Self-citation
The same TCR (N)Dβ(N)Jβ junctional region is associated with several different vβ13 subtypes in a multiple sclerosis patient at the onset of the disease
Démoulins, T., Mouthon, F., Clayette, P., Béquet, D., Gachelin, G., & Dormont, D. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.001 · Cited by 8
Untitled work
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cytokine analysis in multiple sclerosis by competitive RT – PCR: A decreased expression of IL-10 and an increased expression of TNF-α in chronic progression
Huang, W.-X., Huang, P., Link, H., et al. (1999) · Multiple Sclerosis Journal · doi:10.1191/135245899678846401 · Cited by 2
Untitled work
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Untitled work
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Regulation of fucosyltransferase-VII expression in peripheral lymph node high endothelial venules
(1998) · doi:10.1002/(sici)1521-4141(199810)28:10
Untitled work
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Untitled work
Zujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
Untitled work
(1996) · doi:10.1002/(sici)1097-4547(19960915)45:6
Self-citation

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950

See all 2,149

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks